# Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study

> **NCT01417897** · PHASE4 · UNKNOWN · sponsor: **ikfe-CRO GmbH** · enrollment: 12 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Insulin glulisine
- **DRUG:** Insulin aspart
- **DRUG:** Regular human insulin

## Key facts

- **NCT ID:** NCT01417897
- **Lead sponsor:** ikfe-CRO GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2012-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01417897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01417897, "Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01417897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*